NGAL and IL-6 were significantly higher in patients with lower respiratory tract infections compared to healthy controls, but Liu et al. did not observe differences between CAP and AECOPD in their study (49). This evidence concerns the gene LCN2 and Recurrent lower respiratory tract infections.